Skip to main content
BIOF
OTC Industrial Applications And Services

Blue Biofuels Reports Critically Low Cash, Worsening Losses, and Reiterates Going Concern Warning Amidst Significant Funding Gap

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.159
Mkt Cap
$50.929M
52W Low
$0.11
52W High
$0.223
Market data snapshot near publication time

summarizeSummary

Blue Biofuels reported a dramatic drop in cash to $8,665, a significantly increased net loss, and reiterated its going concern warning, emphasizing a critical need for substantial financing.


check_boxKey Events

  • Critically Low Cash Position

    Cash and cash equivalents plummeted to just $8,665 as of March 31, 2026, down from $65,200 at December 31, 2025, indicating a severe liquidity crisis.

  • Worsening Financial Performance

    The company reported a net loss of $(663,801) for Q1 2026, a significant increase from $(243,833) in Q1 2025. The accumulated deficit grew to $60.79 million.

  • Reiterated Going Concern Warning

    Management explicitly stated 'substantial doubt as to the Company's ability to continue as a going concern' due to recurring losses and the inability to generate significant revenue or secure sufficient financing.

  • Inadequate Capital Raises

    During Q1 2026, the company raised $352,000 through private placements and warrant exercises. Subsequent to the quarter, an additional $150,000 was raised via notes, which is a minimal amount compared to the previously stated need for $90 million in financing.


auto_awesomeAnalysis

Blue Biofuels, Inc. faces an extremely precarious financial situation, with cash reserves plummeting to just $8,665 and a net loss that more than doubled year-over-year. The company explicitly reiterates its 'going concern' warning, indicating substantial doubt about its ability to continue operations without significant additional financing. While some capital was raised in Q1 and subsequently, these amounts are negligible compared to the previously disclosed need for $90 million, highlighting a severe funding shortfall. The increasing accumulated deficit and reliance on related-party debt and deferred compensation further underscore the company's financial distress and the urgent need for external capital to sustain its business plan.

At the time of this filing, BIOF was trading at $0.16 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $50.9M. The 52-week trading range was $0.11 to $0.22. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BIOF - Latest Insights

BIOF
May 04, 2026, 12:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
BIOF
Mar 19, 2026, 11:17 AM EDT
Filing Type: 10-K
Importance Score:
9